Company Filing History:
1 out of 1,745 
1 out of 280 
1 out of 25 
Years Active: 2020
Title: Caroline Bret: Innovator in Cancer Treatment
Introduction
Caroline Bret is a notable inventor based in Montpellier, France. She has made significant contributions to the field of cancer research, particularly in the area of diffuse large B-cell lymphoma. Her innovative work focuses on improving treatment responses for patients suffering from this type of cancer.
Latest Patents
Caroline Bret holds a patent for her invention titled "Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma." This patent outlines a method for testing whether a patient will respond to DNA repair pathway inhibitors. The process involves determining the expression levels of specific genes in a biological sample, calculating a DNA repair score, and comparing it to predetermined reference values to predict treatment responses.
Career Highlights
Throughout her career, Caroline has worked with esteemed institutions such as the National Institute of Health and Medical Research and the University of Montpellier. Her research has been pivotal in advancing the understanding of cancer treatment and patient care.
Collaborations
Caroline has collaborated with notable colleagues, including Jerome Moreaux and Guillaume Cartron. These partnerships have enhanced her research and contributed to the development of innovative cancer treatment methods.
Conclusion
Caroline Bret's work exemplifies the impact of innovation in medical research, particularly in oncology. Her contributions continue to influence the way diffuse large B-cell lymphoma is treated, ultimately improving patient outcomes.